Co-pay Coupons and the ACA: Despite HHS Ruling, Insurers Still Hold The Cards
This article was originally published in RPM Report
Executive Summary
The Obama Administration OKs the use of co-pay cards for brand prescription drugs in the ACA-created insurance exchanges. One prominent Republican intends to investigate the decision. But insurers and PBMs can decide whether or not to accept them—a fact being lost in the debate.
You may also be interested in...
Co-Payer Beware? OIG Report Cites Kickback Concerns With Part D Copay Coupons
An HHS Inspector General report finds that manufacturer safeguards may be inadequate to prevent copay coupon use in Medicare Part D. The finding puts CMS in a tricky position – how to limit any chance that coupons inducing use of high-priced brands without cutting off vital support for needy beneficiaries.
Dollars for Donuts: Inside the Key Elements of PhRMA's Health Reform Deal
The key part of PhRMA's deal with the Finance Committee is a double win for industry: assuring that closing the donut hole will be part of reform, and that PhRMA will get credit for a big part of the savings.
Donut Hole Politics: Patient Assistance Under Part D
Big pharma wants to help pick up the costs for patients reaching the coverage gap under Medicare's drug benefit. Medicare's watchdogs at the Inspector General's office are skeptical, but the pharma companies are being persistent.